“In Vivo Delivery of Nucleic Acid-Formulated Microparticles As a Potential Tolerogenic Vaccine for Type 1 Diabetes ”. 2023. The Review of Diabetic Studies 9 (4). https://diabeticstudies.org/index.php/RDS/article/view/184.